Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04514341 · ClinicalTrials.gov registry record
Implementing a Multilevel Intervention to Accelerate Colorectal Cancer Screening and Follow-up
A clinical trial, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- 4
- Enrollment target
NCT04514341: Completed study, sponsored by Milton S. Hershey Medical Center.
NCT04514341 is a clinical trial that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 4 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04514341 has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- 4 participants
- Enrollment target
Study Summary
Screening for colorectal cancer (CRC) not only detects disease early when treatment is more effective but also prevents cancer by finding and removing precancerous polyps. Because many of our nation's most disadvantaged and vulnerable individuals obtain health care at federally qualified health centers, these centers play a significant role in increasing CRC screenings among the most vulnerable populations. Furthermore, the full benefits of cancer screenings must include timely and appropriate follow-up of abnormal results. Thus, the purpose of this study is to implement a multilevel intervention to increase rates of CRC screenings, follow-ups, and referrals-to-care in federally qualified health centers (FQHCs). Also, we will examine the implementation strategies used to support the implementation process and their contribution to the adoption, implementation, and sustainment of the multilevel intervention. The multilevel intervention will target three different levels of influences: organization, provider, and individual. It will have multiple components, including provider and staff education, provider reminder, provider assessment and feedback, patient reminder, and patient navigation. This study is a multilevel, three-phase, stepped wedge cluster randomized trial with four clusters of clinics from four different FQHCs. Our FQHC partners together have 40 primary care clinics and 130 primary care providers. During Phase 1, there will be a 3-month waiting period during which no intervention components will be implemented. After the 3-month waiting period, we will randomize two clusters of clinics to cross from the control to the intervention and the remaining two clusters to follow three months later. All clusters of clinics will stay at the same phase for nine months, followed by a 3-month transition period, and then cross over to the next phase. In Phase 1, we will implement provider and staff education sessions. In Phase 2, we will add provider reminders, patie
Primary Outcome
The number of patients aged 50-75 years who were up-to-date with colorectal cancer screening during each implementation phase.
Interventions
- BEHAVIORAL Intervention Phase 1: Provider and Staff education
- BEHAVIORAL Intervention Phase 2: Provider and staff education + Patient reminder
- BEHAVIORAL Intervention Phase 3: Provider and Staff education + Patient reminder + Patient navigation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2020-09-01 |
| Est. Completion | 2023-12-31 |
What the finished NCT04514341 record still lists
NCT04514341 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 4 participants, a relatively small participant target.
The record links to 0 conditions, and to 3 interventions - of which Intervention Phase 1: Provider and Staff education is the first listed.
NCT04514341 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04514341 about?
NCT04514341 is a clinical study titled "Implementing a Multilevel Intervention to Accelerate Colorectal Cancer Screening and Follow-up". Screening for colorectal cancer (CRC) not only detects disease early when treatment is more effective but also prevents cancer by finding and removing precancerous polyps. Because many of our nation's most disadvantaged and vulnerable individuals obtain health care at federally qualified health cent...
What is the current status of trial NCT04514341?
This trial is currently completed. The enrollment target is 4 participants. The study started on 2020-09-01. Estimated completion is 2023-12-31.
What interventions are being tested in trial NCT04514341?
The interventions under investigation include: Intervention Phase 1: Provider and Staff education (BEHAVIORAL), Intervention Phase 2: Provider and staff education + Patient reminder (BEHAVIORAL), Intervention Phase 3: Provider and Staff education + Patient reminder + Patient navigation (BEHAVIORAL).
Who is sponsoring clinical trial NCT04514341?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI